Please login to the form below

Not currently logged in
Email:
Password:

Galapagos appoints Bart Filius as chief financial officer

He joins from Sanofi where he was CFO for Europe

AppointmentBart Filius has been appointed as chief financial officer at Belhium-based biotech firm Galapagos.

He will start in the role from December 1, 2014, joining the executive committee of the company and will be responsible for finance, investor relations, IT and purchasing.

He joins from Sanofi, where he worked for 13 years. Over the past three years he has worked as chief financial officer at Sanofi Europe, helping the company recover from the patent cliff. Prior to this, he was chief financial officer and country manager of Sanofi in the Netherlands and VP for mergers and acquisitions.

Of his appointment, Filius said: “I am very excited to join Galapagos at this important point of its development. As we move forward and the pipeline matures further, I look forward to bringing my experience in finance and M&A to Galapagos.”

Galapagos announced earlier this year that it sold its Argenta and BioFocus service operations as part of a bid to reorient its business model from a “hybrid drug discovery service and pipeline company” to a research-focused biotech firm.

Onno van de Stolpe, CEO of Galapagos, said: “We are pleased to welcome Bart Filius into our executive team. His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter phase III and progress more programmes into patients next year.”

16th October 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics